Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-09-15 Sale |
2022-09-16 4:33 pm |
Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer |
5,000 | $16.03 | $80,150 | 59,289 (Direct) |
View |
| 2022-09-14 Sale |
2022-09-16 4:28 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
9,000 | $16.01 | $144,090 | 1,188,856 (Indirect Direct) |
View |
| 2022-09-14 Purchase |
2022-09-16 4:24 pm |
Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Director |
18,400 | $16.12 | $296,606 | 6,360 (Indirect) |
View |
| 2022-08-18 Sale |
2022-08-19 4:52 pm |
Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer |
5,000 | $16.3 | $81,500 | 64,289 (Direct) |
View |
| 2022-08-17 Sale |
2022-08-19 4:49 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
8,000 | $16.59 | $132,692 | 1,197,856 (Indirect Direct) |
View |
| 2022-05-05 Purchase |
2022-05-09 4:42 pm |
Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director |
100,000 | $13.5 | $1,350,000 | 1,304,016 (Indirect Direct) |
View |
| 2022-05-05 Sale |
2022-05-05 6:55 pm |
Tarsus Pharmaceuticals Inc. | TARS | Vivo Capital IX LLC Vivo Capital Fund IX L.P. 10% Owner |
5,374 | $12.25 | $65,832 | 2,469,001 (Indirect) |
View |
| 2022-05-02 Sale |
2022-05-04 8:01 pm |
Tarsus Pharmaceuticals Inc. | TARS | Vivo Capital IX LLC Vivo Capital Fund IX L.P. 10% Owner |
512,956 | $13.39 | $6,866,311 | 2,474,375 (Indirect) |
View |
| 2021-12-01 Sale |
2021-12-03 6:56 pm |
Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director |
5,833 | $24.68 | $143,934 | 1,204,016 (Direct) |
View |
| 2021-12-01 Sale |
2021-12-03 6:55 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
5,833 | $24.72 | $144,167 | 1,205,856 (Indirect Direct) |
View |
| 2021-11-08 Sale |
2021-11-10 6:29 pm |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
1,889 | $28.11 | $53,100 | 50,203 (Direct) |
View |
| 2021-11-04 Sale |
2021-11-08 5:49 pm |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
111 | $28.04 | $3,112 | 52,092 (Direct) |
View |
| 2021-11-02 Sale |
2021-11-04 7:03 pm |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
6,000 | $26.78 | $160,690 | 52,203 (Direct) |
View |
| 2021-11-01 Sale |
2021-11-03 7:00 pm |
Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director |
5,833 | $27.82 | $162,289 | 1,209,849 (Direct) |
View |
| 2021-11-01 Sale |
2021-11-03 6:55 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
5,833 | $27.82 | $162,284 | 1,211,689 (Indirect Direct) |
View |
| 2021-10-12 Sale |
2021-10-14 4:48 pm |
Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director |
5,633 | $26.27 | $148,000 | 1,215,682 (Direct) |
View |
| 2021-10-12 Sale |
2021-10-14 4:44 pm |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
5,531 | $26.3 | $145,448 | 1,217,522 (Indirect Direct) |
View |
| 2021-10-08 Sale |
2021-10-12 6:47 pm |
Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director |
200 | $25.03 | $5,006 | 1,221,315 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-08-24 Exercise |
2022-08-26 4:25 pm |
N/A 2028-09-13 |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
772 | $0.45 | 67,159 (Direct) |
View |
| 2022-08-24 Exercise |
2022-08-26 4:25 pm |
N/A 2030-09-24 |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
4,416 | $10.99 | 67,159 (Direct) |
View |
| 2022-08-15 Other |
2022-08-17 4:22 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director |
219,324 | $0 | 362,053 (Indirect) |
View |
| 2022-06-16 Option Award |
2022-07-01 12:31 pm |
N/A 2032-06-15 |
Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director |
19,000 | $0 | 19,000 (Direct) |
View |
| 2022-06-16 Option Award |
2022-07-01 12:30 pm |
N/A 2032-06-15 |
Tarsus Pharmaceuticals Inc. | TARS | CHAUDHURI BHASKAR Director |
9,000 | $0 | 9,000 (Direct) |
View |
| 2022-06-16 Option Award |
2022-07-01 12:29 pm |
N/A 2032-06-15 |
Tarsus Pharmaceuticals Inc. | TARS | YARNO WENDY L Director |
9,000 | $0 | 9,000 (Direct) |
View |
| 2022-06-16 Option Award |
2022-07-01 12:28 pm |
N/A 2032-06-15 |
Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director |
9,000 | $0 | 9,000 (Direct) |
View |
| 2022-06-16 Option Award |
2022-07-01 12:23 pm |
N/A 2032-06-15 |
Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Director |
9,000 | $0 | 9,000 (Direct) |
View |
| 2022-06-16 Option Award |
2022-07-01 12:21 pm |
N/A 2032-06-15 |
Tarsus Pharmaceuticals Inc. | TARS | Goldberg Andrew D. Director |
9,000 | $0 | 9,000 (Direct) |
View |
| 2022-06-16 Option Award |
2022-07-01 12:18 pm |
N/A 2032-06-15 |
Tarsus Pharmaceuticals Inc. | TARS | Crane Rosemary A Director |
9,000 | $0 | 9,000 (Direct) |
View |
| 2022-06-15 Exercise |
2022-06-17 4:51 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director |
4,257 | $0 | 1,308,273 (Direct) |
View |
| 2022-03-09 Option Award |
2022-03-11 4:19 pm |
N/A 2032-03-08 |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO |
199,264 | $0 | 199,264 (Direct) |
View |
| 2022-03-09 Option Award |
2022-03-11 4:17 pm |
N/A 2032-03-08 |
Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer |
89,886 | $0 | 89,886 (Direct) |
View |
| 2022-03-09 Option Award |
2022-03-11 4:15 pm |
N/A 2032-03-08 |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
118,643 | $0 | 118,643 (Direct) |
View |
| 2022-03-09 Option Award |
2022-03-11 4:13 pm |
N/A 2032-03-08 |
Tarsus Pharmaceuticals Inc. | TARS | Holdbrook Mark J. V.P., Clinical Affairs |
46,785 | $0 | 46,785 (Direct) |
View |
| 2022-03-09 Option Award |
2022-03-11 4:10 pm |
N/A 2032-03-08 |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
84,472 | $0 | 84,472 (Direct) |
View |
| 2022-03-09 Option Award |
2022-03-11 4:07 pm |
N/A 2032-03-08 |
Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer |
112,867 | $0 | 112,867 (Direct) |
View |
| 2022-03-09 Option Award |
2022-03-11 4:04 pm |
N/A 2032-03-08 |
Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer |
78,696 | $0 | 78,696 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 5:36 pm |
N/A 2032-01-31 |
Tarsus Pharmaceuticals Inc. | TARS | Trevejo Jose M. CHIEF MEDICAL OFFICER |
146,621 | $0 | 146,621 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-04 9:10 pm |
N/A 2031-12-31 |
Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Director |
20,000 | $0 | 20,000 (Direct) |
View |
Ownership |
2022-01-04 9:09 pm |
N/A 2030-05-13 |
Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Director |
0 | $0 | 45,134 (Direct) |
View |
| 2021-11-11 Other |
2021-11-16 7:58 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director |
254,348 | $0 | 393,328 (Indirect) |
View |